» Articles » PMID: 31049038

Scrambler Therapy for Treatment-Resistant Central Neuropathic Pain in a Patient with Transverse Myelitis

Overview
Journal Int J MS Care
Date 2019 May 4
PMID 31049038
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Central neuropathic pain is a severely disabling consequence of conditions that cause tissue damage in the central nervous system. It is often refractory to treatments commonly used for peripheral neuropathy. Scrambler therapy is an emerging noninvasive pain-modifying technique that uses transcutaneous electrical stimulation of nociceptive fibers with the intent of reorganizing maladaptive signaling pathways. It has been examined for the treatment of peripheral neuropathy with favorable safety and efficacy outcomes, but its application to central neuropathic pain has not been reported in transverse myelitis. We describe the use of Scrambler therapy in a patient with persistent central neuropathic pain due to transverse myelitis. The patient had tried multiple drugs for treatment of the pain, but they were not effective or caused adverse effects. After a course of Scrambler therapy, pain scores improved considerably more than what was reported with previous pharmacologic and nonpharmacologic interventions. This case supports further investigation of Scrambler therapy in multiple sclerosis, neuromyelitis optica spectrum disorder, and other immune-mediated disorders that damage the central nervous system.

Citing Articles

Lumbar decompression and fusion for symptomatic spinal stenosis in a patient with chronic thoracic sensory level from prior transverse myelitis: a case report.

Pesante B, Paro M, Nadeem T, Bulsara K, Choi D J Med Case Rep. 2024; 18(1):42.

PMID: 38310259 PMC: 10838414. DOI: 10.1186/s13256-024-04367-9.


Scrambler Therapy for the Treatment of Pain in Schwannomatosis.

Murphy T, Erdek M, Smith T Cureus. 2022; 14(3):e23124.

PMID: 35464572 PMC: 9001870. DOI: 10.7759/cureus.23124.


Spinal cord stimulator for neuropathic pain in a patient with severe disability due to transverse myelitis.

Martinez Villegas H, Hallo A, Cruz-Loor S, Jacome-Calderon K BMJ Case Rep. 2021; 14(5).

PMID: 34011645 PMC: 8137221. DOI: 10.1136/bcr-2021-242522.


Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.

Mealy M, Kozachik S, Cook L, Totonis L, Salazar R, Allen J Neurology. 2020; 94(18):e1900-e1907.

PMID: 32269109 PMC: 7274926. DOI: 10.1212/WNL.0000000000009370.


Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information.

Marineo G Integr Cancer Ther. 2019; 18:1534735419845143.

PMID: 31014125 PMC: 6482660. DOI: 10.1177/1534735419845143.

References
1.
. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002; 59(4):499-505. DOI: 10.1212/wnl.59.4.499. View

2.
Dworkin R, OConnor A, Backonja M, Farrar J, Finnerup N, Jensen T . Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007; 132(3):237-251. DOI: 10.1016/j.pain.2007.08.033. View

3.
DeSantana J, Walsh D, Vance C, Rakel B, Sluka K . Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep. 2008; 10(6):492-9. PMC: 2746624. DOI: 10.1007/s11926-008-0080-z. View

4.
Nick S, Roberts C, Billiodeaux S, Davis D, Zamanifekri B, Sahraian M . Multiple sclerosis and pain. Neurol Res. 2012; 34(9):829-41. DOI: 10.1179/1743132812Y.0000000082. View

5.
Qian P, Lancia S, Alvarez E, Klawiter E, Cross A, Naismith R . Association of neuromyelitis optica with severe and intractable pain. Arch Neurol. 2012; 69(11):1482-7. PMC: 3561507. DOI: 10.1001/archneurol.2012.768. View